As of Jun 21
| +0.0392 / +5.52%|
The 2 analysts offering 12-month price forecasts for Acasti Pharma Inc have a median target of 4.30, with a high estimate of 5.47 and a low estimate of 3.13. The median estimate represents a +473.48% increase from the last price of 0.75.
The current consensus among 2 polled investment analysts is to Buy stock in Acasti Pharma Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.